Medicrea Reports Third Quarter 2019 Financial Results

The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the digital transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, reports its unaudited results for the third quarter of 2019.

€’million

H1 2019

 Q3 2019

YTD
09-2019

YTD
09-2018
(2) Restated

Sales

16.1

8.2

24.3

24.3

Gross margin - % of sales

77%

82%

79%

70%

EBITDA (1)

0.6

1.6

2.1

0.2

Operating income

(3.4)

(1.1)

(4.5)

(5.8)

Other operating income and expense

(0.5)

(0.1)

(0.6)

(0.5)

Share-based payments

(1.0)

(0.5)

(1.5)

(0.6)

Cost of net financial debt

(2.0)

(2.3)

(4.3)

(2.0)

Income before taxes

(6.9)

(4.0)

(10.9)

(8.9)

Net Income

(7.0)

(4.4)

(11.4)

(8.7)